Back to News
Market Impact: 0.35
Smith & Nephew Q3 Revenues Rise, Cuts FY26 Outlook; Continues To Explore Options For Orthopaedics
Source: Nasdaq
Corporate EarningsCorporate Guidance & OutlookHealthcare & BiotechCompany Fundamentals
Smith & Nephew reported higher third-quarter revenue, with growth across all regions, but trimmed its fiscal 2026 guidance. The company attributed the revision to slower-than-expected growth in Orthopaedics; the available article text provides no revenue figures or revised guidance amounts.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment
SNN-0.30
More News
- Smith+Nephew cuts guidance on weak orthopaedics demand
- NextDC shares surge 43% after Goodman, Digital Realty stake purchases
- Voters rebuff data centers in every ballot measure except one during the 2026 midterms
- Qualcomm issues disappointing earnings forecast as memory shortage weighs on smartphone sales
- ‘Seismic’ blue wave triggers the sinking of oil prices, energy stocks, and the chances of power permitting reform
- Softbank’s $5.4 bln takeover of ABB robotics unit blocked by China- FT